196 related articles for article (PubMed ID: 26759926)
1. An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer.
Ji T; Li S; Zhang Y; Lang J; Ding Y; Zhao X; Zhao R; Li Y; Shi J; Hao J; Zhao Y; Nie G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):3438-45. PubMed ID: 26759926
[TBL] [Abstract][Full Text] [Related]
2. Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy.
Ji T; Lang J; Wang J; Cai R; Zhang Y; Qi F; Zhang L; Zhao X; Wu W; Hao J; Qin Z; Zhao Y; Nie G
ACS Nano; 2017 Sep; 11(9):8668-8678. PubMed ID: 28806504
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M
Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422
[TBL] [Abstract][Full Text] [Related]
4. Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma.
Li Y; Zhao Z; Liu H; Fetse JP; Jain A; Lin CY; Cheng K
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45390-45403. PubMed ID: 31769963
[TBL] [Abstract][Full Text] [Related]
5. Key role of pancreatic stellate cells in pancreatic cancer.
Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
Cancer Lett; 2016 Oct; 381(1):194-200. PubMed ID: 26571462
[TBL] [Abstract][Full Text] [Related]
6. Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem.
Han X; Li Y; Xu Y; Zhao X; Zhang Y; Yang X; Wang Y; Zhao R; Anderson GJ; Zhao Y; Nie G
Nat Commun; 2018 Aug; 9(1):3390. PubMed ID: 30139933
[TBL] [Abstract][Full Text] [Related]
7. Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer.
Horioka K; Ohuchida K; Sada M; Zheng B; Moriyama T; Fujita H; Manabe T; Ohtsuka T; Shimamoto M; Miyazaki T; Mizumoto K; Oda Y; Nakamura M
Int J Oncol; 2016 Apr; 48(4):1499-508. PubMed ID: 26846197
[TBL] [Abstract][Full Text] [Related]
8. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.
Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A
J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912
[TBL] [Abstract][Full Text] [Related]
9. [The impact of desmoplasia and pancreatic stellate cells on pancreatic cancer].
Nielsen MF; Mortensen MB; Detlefsen S
Ugeskr Laeger; 2015 Aug; 177(34):. PubMed ID: 26320589
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility.
Sada M; Ohuchida K; Horioka K; Okumura T; Moriyama T; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Nakamura M
Cancer Lett; 2016 Mar; 372(2):210-8. PubMed ID: 26805763
[TBL] [Abstract][Full Text] [Related]
11. Targeting ROCK2 improves macromolecular permeability in a 3D fibrotic pancreatic cancer microenvironment model.
Tanaka HY; Nakazawa T; Miyazaki T; Cabral H; Masamune A; Kano MR
J Control Release; 2024 May; 369():283-295. PubMed ID: 38522816
[TBL] [Abstract][Full Text] [Related]
12. Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment.
Kang Z; Wang C; Tong Y; Li Y; Gao Y; Hou S; Hao M; Han X; Wang B; Wang Q; Zhang C
J Med Chem; 2021 Jan; 64(1):629-643. PubMed ID: 33381963
[TBL] [Abstract][Full Text] [Related]
13. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.
Apte MV; Wilson JS
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():69-74. PubMed ID: 22320920
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer.
Lu T; Prakash J
Int J Nanomedicine; 2021; 16():6313-6328. PubMed ID: 34552327
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness.
Tanaka HY; Kitahara K; Sasaki N; Nakao N; Sato K; Narita H; Shimoda H; Matsusaki M; Nishihara H; Masamune A; Kano MR
Biomaterials; 2019 Feb; 192():355-367. PubMed ID: 30476717
[TBL] [Abstract][Full Text] [Related]
17. Sequential Delivery of Quercetin and Paclitaxel for the Fibrotic Tumor Microenvironment Remodeling and Chemotherapy Potentiation via a Dual-Targeting Hybrid Micelle-in-Liposome System.
Duan H; Liu C; Hou Y; Liu Y; Zhang Z; Zhao H; Xin X; Liu W; Zhang X; Chen L; Jin M; Gao Z; Huang W
ACS Appl Mater Interfaces; 2022 Mar; 14(8):10102-10116. PubMed ID: 35175043
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic stellate cells: A dynamic player of the intercellular communication in pancreatic cancer.
Masamune A; Shimosegawa T
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S98-103. PubMed ID: 26189983
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Stellate Cells: The Key Orchestrator of The Pancreatic Tumor Microenvironment.
Thomas D; Radhakrishnan P
Adv Exp Med Biol; 2020; 1234():57-70. PubMed ID: 32040855
[TBL] [Abstract][Full Text] [Related]
20. Thermosensitive Liposomal Codelivery of HSA-Paclitaxel and HSA-Ellagic Acid Complexes for Enhanced Drug Perfusion and Efficacy Against Pancreatic Cancer.
Wei Y; Wang Y; Xia D; Guo S; Wang F; Zhang X; Gan Y
ACS Appl Mater Interfaces; 2017 Aug; 9(30):25138-25151. PubMed ID: 28696100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
